Connection

Robert Harrington to Pyrroles

Back to Details
This is a "connection" page, showing publications Robert Harrington has written about Pyrroles.
Robert Harrington
Connection Strength
0.028
Pyrroles
  1. Effect of alirocumab, a monoclonal antibody to PCSK9, on long-term cardiovascular outcomes following acute coronary syndromes: rationale and design of the ODYSSEY outcomes trial. Am Heart J. 2014 Nov; 168(5):682-9.
    View in: PubMed
    Score: 0.028
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.